Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Impact in
- Oncology 253
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w44170653 →Countries where authors are citing Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
This map shows the geographic impact of Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). more than expected).
Fields of papers citing Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
This network shows the impact of Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)..
About Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
This paper, published in 2001, received 474 indexed citations . Written by Pedram Argani, Christine A. Iacobuzio–Donahue, Byungwoo Ryu, Christophe Rosty, Michael Goggins, Robb E. Wilentz, Selva R. Murugesan, Steven D. Leach, Elizabeth M. Jaffee and Charles J. Yeo covering the research area of Pulmonary and Respiratory Medicine. It is primarily cited by scholars working on Oncology (253 citations), Pulmonary and Respiratory Medicine (150 citations), Immunology (98 citations), Molecular Biology (93 citations) and Biotechnology (62 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w44170653.